Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Profile
Holly Bullock
Assistant Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Obstetrics and Gynecology
Overview
Research
More
Collaboration
(1)
Steven Dudick
Mutual work: 1 Publication
Collaboration Details
Grants
(1)
Control of Bleeding on Nexplanon in Latinx Patients
2021
·
$369.6K
·
External
Principal Investigator (PI)
contraception,
women's health,
ethnic health disparities,
bleeding management,
implantable contraceptives
Publications
(38)
Recent
Society of Family Planning Annual Meeting 2023
2023
family planning,
reproductive health,
public health,
conference,
healthcare policy
“THAT’SA TRICKY ONE”: ACCESS TO MISOPROSTOL FOR EARLY PREGNANCY LOSS IN RETAIL PHARMACIES ACROSS ARIZONA
2023
reproductive health,
pharmacy practice,
medication availability,
pregnancy loss,
medication regulation
2021 Society of Family Planning Annual Meeting, October 1-2, 2021
2021
family planning,
society,
annual meeting,
conferences
Cell-Free DNA as an Addition to Ultrasound for Screening of a Complete Hydatidiform Mole and Coexisting Normal Fetus Pregnancy: A Case Report.
2020
prenatal screening,
gynecology,
genetic testing,
obstetrics,
case report
"The Difference between Planand ella®? They're Basically the Same Thing" Results from a Mystery Client Study.
2020
consumer behavior,
brand perception,
market research,
product comparison,
customer satisfaction
Society of Family Planning Annual Meeting 2020–Scientific abstracts, October 9-10, 2020
2020
family planning,
scientific research,
annual meeting,
society,
abstracts
“The difference between Planand ella®? They’re basically the same thing”: results from a mystery client study
2020
consumer research,
market analysis,
brand comparison,
customer feedback,
product evaluation
Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah's Title X clinics: a retrospective review.
2018
contraceptive devices,
cost analysis,
family planning,
reproductive health,
healthcare policy
Pharmacy access to Ulipristal acetate in major cities throughout the United States
2018
pharmacy access,
ulipristal acetate,
major cities,
united states,
pharmacy distribution
Increasing options for vasectomy counseling and services at Planned Parenthood of Utah
2018
family planning,
reproductive health,
contraception,
sexual health,
healthcare access
